Application of the structured history taking of medication use tool to optimise prescribing for older patients and reduce adverse events

International Journal of Clinical Pharmacy
Shane CullinanStephen Byrne

Abstract

Older patients, due to polypharmacy, co-morbidities and often multiple prescribing doctors are particularly susceptible to medication history errors, leading to adverse drug events, patient harm and increased costs. Medication reconciliation at the point of admission to hospital can reduce medication discrepancies and adverse events. The Structured HIstory taking of Medication use (SHiM) tool was developed to provide a structure to the medication reconciliation process. There has been very little research with regards to SHiM, it's application to older patients and it's potential to reduce adverse events. To determine whether application of SHiM could optimise older patients' prescriptions on admission to hospital, and in-turn reduce adverse events, compared to standard care. A sub-study of a large clinical trial involving hospital inpatients over the age of 65 in five hospitals across Europe. A modified version of SHiM was used to obtain accurate drug histories for patients after the attending physician had obtained a medication list via standard methods. Discrepancies between the two lists were recorded and classified, and the clinical relevance of the discrepancies was determined. Whether discrepancies in patients' medicatio...Continue Reading

References

Jan 22, 1997·JAMA : the Journal of the American Medical Association·D W BatesL L Leape
Aug 13, 1998·The Medical Journal of Australia·P A AtkinG M Shenfield
Oct 9, 2003·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Ryan D Michels, Steven B Meisel
Jan 24, 2004·Joint Commission Journal on Quality and Safety·John D RozichRoger K Resar
Nov 16, 2004·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Kristine M GleasonGary A Noskin
Mar 2, 2005·Archives of Internal Medicine·Patricia L CornishEdward E Etchells
Sep 1, 2005·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Vincent C TamEdward E Etchells
Apr 6, 2006·Quality & Safety in Health Care·T ViraE Etchells
Apr 26, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Todd A Reeder, Alan Mutnick
Jun 20, 2008·Journal of General Internal Medicine·Jennifer R PippinsJeffrey L Schnipper
Jul 15, 2009·British Journal of Clinical Pharmacology·Richard J Fitzgerald
Dec 4, 2009·Journal of Managed Care Pharmacy : JMCP·Terri L WarholakWilliam Fritz
May 5, 2010·The American Journal of Geriatric Pharmacotherapy·Kathleen Tschantz UnroeCathleen Colón-Emeric
Jul 3, 2010·Quality & Safety in Health Care·Sabrina De WinterLudo Willems
May 11, 2011·Archives of Internal Medicine·Kenneth S BoockvarJessica Yeh
Nov 19, 2011·Journal of the American Geriatrics Society·A Clara Drenth-van MaanenRob J van Marum
Apr 5, 2012·BMC Clinical Pharmacology·Lina M HellströmTommy Eriksson
Sep 14, 2012·International Journal of Clinical Pharmacy·Mairead GalvinTamasine Grimes

❮ Previous
Next ❯

Citations

Mar 7, 2020·Journal of the American Geriatrics Society·Sydney B Ross MSc CandidateEmily G McDonald
Jun 20, 2019·Pharmacy : Journal of Pharmacy, Education and Practice·Geoffrey TwiggJoshua Taylor
Mar 31, 2017·Drug Safety - Case Reports·Pierre-Marie MoriceXavier Humbert
Jan 1, 2017·European Journal of Hospital Pharmacy. Science and Practice·Shane CullinanLaura Sahm

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing
Jennifer Balon, Stephanie A Thomas
Ugeskrift for laeger
Dorthe Vilstrup Tomsen, Mette Bjeldbak-Olesen
International Journal of Clinical Pharmacy
Jolene Pilegaaard HenriksenLise Aagaard
© 2022 Meta ULC. All rights reserved